Upgrade to SI Premium - Free Trial

Cantor Fitzgerald Reiterates Overweight Rating on Surgery Partners (SGRY), Highlights Improved Cash Conversion

August 11, 2026 9:49 AM
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $18.00 price target on Surgery Partners (NASDAQ: SGRY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments